bemnifosbuvir
bemnifosbuvir: 2 clinical trials tracked.
bemnifosbuvir evidence translation
What we can confirm
2 tracked trials
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about bemnifosbuvir, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (2)
A Phase 2, Open-label Study to Assess the Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic Hepatitis C Virus (HCV) Infection
Primary endpoint: Percentage of Subjects Achieving Sustained Virologic Response at 12 Weeks Post-treatment (SVR12)
Interventionalopen275 enrolledStarted 2023-05Completion 2025-0150 sites · Brazil, Canada, India, Mauritius…Atea Pharmaceuticals, Inc.
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
Primary endpoint: Percentage of Subjects Hospitalized for Any Cause or Died Due to Any Cause
InterventionalRandomizedtriple2,285 enrolledStarted 2022-11Completion 2024-0550 sites · United StatesAtea Pharmaceuticals, Inc.